MedTrace Logo

Spatial Repellent Products for the Control of Vector Borne Diseases - Malaria - Kenya

NCT02294201 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2016-10-06

No results posted yet for this study

Summary

The primary objective of the study is to demonstrate and quantify the protective efficacy (PE) of spatial repellent products in reducing the incidence of malaria infection in human cohorts. The null hypothesis (H0) is that there is no difference in malaria incidence between intervention and control arms.

Conditions

Interventions

DEVICE

Spatial Repellent product with active ingredient

Spatial Repellent product

DEVICE

Active ingredient

Transfluthrin (Active ingredient)

DEVICE

Spatial Repellent product without active ingredient (SHIELD)

Spatial Repellent Product - Passive Emanator. The name of the product is SHIELD from SCJohnson

Sponsors & Collaborators

Principal Investigators

  • Neil Lobo, PhD · University of Notre Dame

  • Nicole Achee, PhD · University of Notre Dame

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
59 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • Kenya

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02294201 on ClinicalTrials.gov